148 related articles for article (PubMed ID: 36644821)
21. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
[TBL] [Abstract][Full Text] [Related]
22. Qishen Taohong Granule () as Adjuvant Therapy for Improving Cardiac Function and Quality of Life in Patients with Chronic Heart Failure: A Randomized Controlled Trial.
Li XX; Wu Y; Fan ZJ; Cui J; Li D; Lin Q; Zhuang R; Yan RK; Lin Q; Li Y
Chin J Integr Med; 2022 Jan; 28(1):12-19. PubMed ID: 34387827
[TBL] [Abstract][Full Text] [Related]
23. The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings.
Mazza A; Townsend DM; Torin G; Schiavon L; Camerotto A; Rigatelli G; Cuppini S; Minuz P; Rubello D
Biomed Pharmacother; 2020 Oct; 130():110596. PubMed ID: 34321170
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study.
Tsutsui H; Momomura S; Saito Y; Ito H; Yamamoto K; Ohishi T; Okino N; Guo W
J Cardiol; 2017 Sep; 70(3):225-231. PubMed ID: 28024961
[TBL] [Abstract][Full Text] [Related]
25. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
26. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
Naser N
Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
[TBL] [Abstract][Full Text] [Related]
27. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
28. Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: A systematic review and network meta-analysis of randomized clinical trials.
Bao J; Kan R; Chen J; Xuan H; Wang C; Li D; Xu T
Pharmacol Res; 2021 Jul; 169():105573. PubMed ID: 33766629
[TBL] [Abstract][Full Text] [Related]
29. Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study.
Navarro-Peñalver M; Perez-Martinez MT; Gómez-Bueno M; García-Pavía P; Lupón-Rosés J; Roig-Minguell E; Comin-Colet J; Bayes-Genis A; Noguera JA; Pascual-Figal DA
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):543-550. PubMed ID: 29929385
[TBL] [Abstract][Full Text] [Related]
30. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial.
Lewis GD; Malhotra R; Hernandez AF; McNulty SE; Smith A; Felker GM; Tang WHW; LaRue SJ; Redfield MM; Semigran MJ; Givertz MM; Van Buren P; Whellan D; Anstrom KJ; Shah MR; Desvigne-Nickens P; Butler J; Braunwald E;
JAMA; 2017 May; 317(19):1958-1966. PubMed ID: 28510680
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
Butt JH; Adamson C; Docherty KF; de Boer RA; Petrie MC; Inzucchi SE; Kosiborod MN; Maria Langkilde A; Lindholm D; Martinez FA; Bengtsson O; Schou M; O'Meara E; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV; Køber L
Circ Heart Fail; 2021 Dec; 14(12):e008837. PubMed ID: 34802253
[TBL] [Abstract][Full Text] [Related]
32. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
Nassif ME; Windsor SL; Tang F; Khariton Y; Husain M; Inzucchi SE; McGuire DK; Pitt B; Scirica BM; Austin B; Drazner MH; Fong MW; Givertz MM; Gordon RA; Jermyn R; Katz SD; Lamba S; Lanfear DE; LaRue SJ; Lindenfeld J; Malone M; Margulies K; Mentz RJ; Mutharasan RK; Pursley M; Umpierrez G; Kosiborod M
Circulation; 2019 Oct; 140(18):1463-1476. PubMed ID: 31524498
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial.
Bundgaard H; Axelsson Raja A; Iversen K; Valeur N; Tønder N; Schou M; Christensen AH; Bruun NE; Søholm H; Ghanizada M; Fry NAS; Hamilton EJ; Boesgaard S; Møller MB; Wolsk E; Rossing K; Køber L; Rasmussen HH; Vissing CR
Circ Heart Fail; 2022 Jul; 15(7):e009120. PubMed ID: 35758031
[TBL] [Abstract][Full Text] [Related]
34. Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single-centre experience.
Blanco C; Madej T; Mangner N; Hommel J; Grimm S; Knaut M; Linke A; Winzer EB
ESC Heart Fail; 2023 Dec; 10(6):3373-3384. PubMed ID: 37667319
[TBL] [Abstract][Full Text] [Related]
35. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
Fisher SA; Brunskill SJ; Doree C; Mathur A; Taggart DP; Martin-Rendon E
Cochrane Database Syst Rev; 2014 Apr; (4):CD007888. PubMed ID: 24777540
[TBL] [Abstract][Full Text] [Related]
36. Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
Ahmed M; Nudy M; Bussa R; Weigel F; Naccarelli G; Maheshwari A
Trends Cardiovasc Med; 2024 Feb; 34(2):101-107. PubMed ID: 36202286
[TBL] [Abstract][Full Text] [Related]
37. Effects of Repetitive Transendocardial CD34
Vrtovec B; Poglajen G; Sever M; Zemljic G; Frljak S; Cerar A; Cukjati M; Jaklic M; Cernelc P; Haddad F; Wu JC
Circ Res; 2018 Jul; 123(3):389-396. PubMed ID: 29880546
[TBL] [Abstract][Full Text] [Related]
38. The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial.
Martens P; Dupont M; Dauw J; Nijst P; Herbots L; Dendale P; Vandervoort P; Bruckers L; Tang WHW; Mullens W
Eur Heart J; 2021 Dec; 42(48):4905-4914. PubMed ID: 34185066
[TBL] [Abstract][Full Text] [Related]
39. Cardio-microcurrent device for chronic heart failure: first-in-human clinical study.
Kosevic D; Wiedemann D; Vukovic P; Ristic V; Riebandt J; Radak U; Brandes K; Goettel P; Duengen HD; Tahirovic E; Kottmann T; Voss HW; Zdravkovic M; Putnik S; Schmitto JD; Mueller J; Rame JE; Peric M
ESC Heart Fail; 2021 Apr; 8(2):962-970. PubMed ID: 33559358
[TBL] [Abstract][Full Text] [Related]
40. Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.
Patel AN; Henry TD; Quyyumi AA; Schaer GL; Anderson RD; Toma C; East C; Remmers AE; Goodrich J; Desai AS; Recker D; DeMaria A;
Lancet; 2016 Jun; 387(10036):2412-21. PubMed ID: 27059887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]